12/14/21 - Virginia student leads way in national muscular dystrophy trial

Myotonic dystrophy, known as DM1, is the most common type of muscular dystrophy worldwide, and it has no effective treatment. But a Virginia college student recently became the first participant in a national trial for a drug that targets DM1 at the source; Fairfax County Public Schools has settled a lawsuit with parents and disability rights advocates over the district’s use of seclusion and restraint with students with disabilities; Virginia’s legislative agencies were forced to shut down computer systems and websites due to a ransomware attack; and other local news stories.